羚锐制药：2025年第三季度归属于上市公司股东的净利润同比增长9.77%

Core Insights - The company reported a revenue of 942,156,123.36 yuan for the third quarter of 2025, representing a year-on-year growth of 10.44% [1] - The net profit attributable to shareholders of the listed company was 176,546,803.24 yuan, showing a year-on-year increase of 9.77% [1]